- Side effects account for most of the instances of failure of candidate drugs at late stages of development. These development failures contribute to the exorbitant cost of bringing new compounds to market: a single withdrawal can represent a loss of more than $1 billion. Many unwanted actions of drugs affect the heart, resulting in potentially proarrhythmic alteration of ion channel function. Because these can be fatal, potential electrophysiological cardiotoxicity is among the most stringent exclusion criteria in the licensing process.
- Publication status:
- Publisher copy:
- Copyright date:
The systems biology approach to drug development: application to toxicity assessment of cardiac drugs.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record